U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07936942) titled 'Quality of Life and Uremic Toxins in HDx' on Nov. 08.
Brief Summary: Expanded hemodialysis (HDx) is a dialysis treatment designed to improve the removal of certain waste products from the blood. However, its effects on health-related quality of life and blood levels of uremic toxins in patients receiving long-term hemodialysis remain uncertain.
This study aimed to evaluate changes in quality of life and uremic toxin levels after switching from conventional hemodialysis to HDx. Patients who had been receiving maintenance hemodialysis for at least 10 years underwent HDx for three months. Quality of life and blood levels of selected u...